Arcturus Therapeutics Holdings Inc (ARCT) — Cash Flow Quality Index
Arcturus Therapeutics Holdings Inc (ARCT) has a Cash Flow Quality Index of -0.71x as of March 2023. Operating cash flow of $-35.87 Million is below net income of $50.75 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore ARCT long-term investments to assets to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Arcturus Therapeutics Holdings Inc Cash Flow Quality Index (2022–2022)
Historical Cash Flow Quality Index for Arcturus Therapeutics Holdings Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible equity quality of Arcturus Therapeutics Holdings Inc to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Arcturus Therapeutics Holdings Inc (2022–2022)
Year-by-year earnings quality comparison for Arcturus Therapeutics Holdings Inc. For live market cap and the full company financial profile, see Arcturus Therapeutics Holdings Inc (ARCT) total market value.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 3.42x | $31.99 Million | $9.35 Million | — |